Calorie restriction-mediated restoration of hypothalamic signal transducer and activator of transcription 3 (STAT3) phosphorylation is not effective for lowering the body weight set point in IRS-2 knockout obese mice

Abstract

Aim/hypothesis Lowering the body weight set point is a prerequisite for the maintenance of reduced body weight. In this context, obesity is known to be strongly linked to leptin resistance, and it remains to be clarified whether recovery from leptin resistance might lower the body weight set point to allow sustained body weight loss. Methods Obese IRS-2 knockout (IRS-2 -/-) mice were subjected to calorie restriction (CR) or b3-adrenergic receptor (AR) agonist treatment. The physiological effects of leptin, hypothalamic leptin signaling, and alterations of the body weight set point were evaluated. Results In the CR mice, recovery from acquired leptin resistance was observed, as shown by the restoration of the suppressive effects of leptin on food intake and weight gain, as well as the recovery of signal transducer and activator of transcription 3 (STAT3) phosphorylation. Nevertheless, the body weight quickly rebounded to the original body weight after cessation of the CR, suggesting that CR failed to overcome the primary defect in IRS-2/ phosphatidylinositol 3-kinase (PI3K) signaling. On the other hand, after 2 weeks b3-AR agonist treatment, the mice began to lose body weight, indicating that the treatment was able to overcome the primary defect in IRS-2/ PI3K signaling and lower the body weight set point. Conclusions/interpretation Recovery of acquired leptin resistance does not lead to a resetting of the body weight set point in obese IRS-2/PI3K-defective mice. b3-AR agonist treatment may act on some pathways distal to or independent of PI3K and/or STAT3, inducing resetting of the body weight set point. Keywords b3-adrenergic receptor agonist Á Body weight set point Á Calorie restriction Á IRS-2 -/mice Á Leptin resistance Á Signal transducer and activator of transcription 3 (STAT3)

Umbelliferone attenuates unpredictable chronic mild stress induced‐insulin resistance in rats

“…The cellular events in muscle of diabetic rats lead to the state of decreased glucose uptake and insulin resistance, which elicits further exaggeration of imbalanced glucose metabolism . On binding to IRS proteins, PI3K is activated, and then PI3K/Akt pathway is involved in insulin‐stimulated increase of glucose transport . Furthermore, on activation, GSK‐3β would also conduce to the consumption of glucose, which suggested the upregulation of GSK‐3β benefits in the recovery of patients with diabetes .…”

α-Glucosidase Inhibitory, Anti-Oxidant, and Anti-Hyperglycemic Effects of Euphorbia nivulia–Ham. in STZ-Induced Diabetic Rats

“…Traditional medicinal practices formed the basis of most of the early medicines followed by subsequent clinical, pharmacological, and chemical studies. 11 - 17 , 40 - 46 Plants have been well-documented for their medicinal uses for thousands of years. 47 They have evolved and adapted over millions of years to withstand bacteria, insects, fungi, and weather to produce unique, structurally diverse secondary metabolites.…”